PHOTOMONTAGE Topic picture, symbol photo Corona vaccine Pfizer and BioNTech announce successful first interim analysis of their COVID 19 vaccine candidate in ongoing phase 3 study Vaccine doses with vaccine BIONTECH Biotechnology Company

PHOTOMONTAGE Topic picture, symbol photo Corona vaccine Pfizer and BioNTech announce successful first interim analysis of their COVID 19 vaccine candidate in ongoing phase 3 study Vaccine doses with vaccine BIONTECH Biotechnology Company

Choose your license

Rights Managed:

One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.

One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.

Media Info

Credit: Sven Simon

Media ID:

Recording Date: Nov 20, 2020

Media Size: 5,568×3,712 Pixels

PHOTOMONTAGE Topic picture, symbol photo Corona vaccine Pfizer and BioNTech announce successful first interim analysis of their COVID 19 vaccine candidate in ongoing phase 3 study Vaccine doses with vaccine BIONTECH Biotechnology Company

Release Info: Do I need a release?

Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.

Need a custom license?

If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.